Global Antidiuretic Hormone (ADH) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antidiuretic Hormone (ADH) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
ADH is a hormone stored in the posterior pituitary gland in the brain, regulating water levels in the body. ADH interacts with the kidneys to increase total body water increasing blood volume and blood pressure. The release of ADH is controlled by cells called osmoreceptors and baroreceptors.
Antidiuretic Hormone (ADH) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidiuretic Hormone (ADH) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Anti-Diuretic Hormone Deficiency and Vasodilatory Shock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antidiuretic Hormone (ADH) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antidiuretic Hormone (ADH) key manufacturers include Novartis, Pfizer, Fresenius Kabi, Par Pharmaceutical, Ferring Pharmaceuticals, Astellas Pharma and Shanghai Soho-Yiming Pharmaceuticals, etc. Novartis, Pfizer, Fresenius Kabi are top 3 players and held % sales share in total in 2022.
Antidiuretic Hormone (ADH) can be divided into Intravenous Injection, Intramuscular Injection and Subcutaneous Injection,, etc. Intravenous Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Antidiuretic Hormone (ADH) is widely used in various fields, such as Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding and Ventricular Tachycardia & Fibrillation, etc. Anti-Diuretic Hormone Deficiency provides greatest supports to the Antidiuretic Hormone (ADH) industry development. In 2022, global % sales of Antidiuretic Hormone (ADH) went into Anti-Diuretic Hormone Deficiency filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidiuretic Hormone (ADH) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Pfizer
Fresenius Kabi
Par Pharmaceutical
Ferring Pharmaceuticals
Astellas Pharma
Shanghai Soho-Yiming Pharmaceuticals
Segment by Type
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection
Anti-Diuretic Hormone Deficiency
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia & Fibrillation
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antidiuretic Hormone (ADH) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidiuretic Hormone (ADH), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidiuretic Hormone (ADH) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antidiuretic Hormone (ADH) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidiuretic Hormone (ADH) introduction, etc. Antidiuretic Hormone (ADH) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antidiuretic Hormone (ADH) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Antidiuretic Hormone (ADH) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidiuretic Hormone (ADH) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Anti-Diuretic Hormone Deficiency and Vasodilatory Shock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antidiuretic Hormone (ADH) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antidiuretic Hormone (ADH) key manufacturers include Novartis, Pfizer, Fresenius Kabi, Par Pharmaceutical, Ferring Pharmaceuticals, Astellas Pharma and Shanghai Soho-Yiming Pharmaceuticals, etc. Novartis, Pfizer, Fresenius Kabi are top 3 players and held % sales share in total in 2022.
Antidiuretic Hormone (ADH) can be divided into Intravenous Injection, Intramuscular Injection and Subcutaneous Injection,, etc. Intravenous Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Antidiuretic Hormone (ADH) is widely used in various fields, such as Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding and Ventricular Tachycardia & Fibrillation, etc. Anti-Diuretic Hormone Deficiency provides greatest supports to the Antidiuretic Hormone (ADH) industry development. In 2022, global % sales of Antidiuretic Hormone (ADH) went into Anti-Diuretic Hormone Deficiency filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidiuretic Hormone (ADH) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Pfizer
Fresenius Kabi
Par Pharmaceutical
Ferring Pharmaceuticals
Astellas Pharma
Shanghai Soho-Yiming Pharmaceuticals
Segment by Type
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection
Segment by Application
Anti-Diuretic Hormone Deficiency
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia & Fibrillation
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antidiuretic Hormone (ADH) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidiuretic Hormone (ADH), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidiuretic Hormone (ADH) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antidiuretic Hormone (ADH) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidiuretic Hormone (ADH) introduction, etc. Antidiuretic Hormone (ADH) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antidiuretic Hormone (ADH) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices